Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04001426 · ClinicalTrials.gov registry record · NA
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device
A NA study, sponsored by FemPulse Corporation.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04001426: Completed NA study, sponsored by FemPulse Corporation.
NCT04001426 is a NA study that has completed, run by FemPulse Corporation. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04001426, a NA study, has completed, sponsored by FemPulse Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
Primary Outcome
The Quantitative Sudomotor Axon Reflex Test (QSART) will be used to detect changes in autonomic nervous system activity during device activation
Interventions
- DEVICE The FemPulse System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT04001426 record still lists
NCT04001426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which The FemPulse System is the first listed.
NCT04001426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04001426 about?
NCT04001426 is a clinical study titled "Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device". The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
What is the current status of trial NCT04001426?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2019-04-04. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT04001426?
The interventions under investigation include: The FemPulse System (DEVICE).
Who is sponsoring clinical trial NCT04001426?
This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04001426's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI